ABOUT THE PRODUCT
Helixomer’s patented RNA origami (RNAO) platform enables the creation of highly effective nanodrugs with enhanced targeting and delivery capabilities. This platform is at the core of our drug design and development process.
Information is owner-confirmed
Last updated 1 month ago
Price range
Other products/services from Helixomer
Aptamer-Based Therapeutics
Biotechnology
N/A
Helixomer
United States (US)